U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C21H27N3O7S.ClH
Molecular Weight 501.981
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BACAMPICILLIN HYDROCHLORIDE

SMILES

Cl.[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C3=CC=CC=C3)C(=O)OC(C)OC(=O)OCC

InChI

InChIKey=IWVTXAGTHUECPN-ANBBSHPLSA-N
InChI=1S/C21H27N3O7S.ClH/c1-5-29-20(28)31-11(2)30-19(27)15-21(3,4)32-18-14(17(26)24(15)18)23-16(25)13(22)12-9-7-6-8-10-12;/h6-11,13-15,18H,5,22H2,1-4H3,(H,23,25);1H/t11?,13-,14-,15+,18-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C21H27N3O7S
Molecular Weight 465.52
Charge 0
Count
Stereochemistry EPIMERIC
Additional Stereochemistry No
Defined Stereocenters 4 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/6762528 | http://www.antimicrobe.org/drugpopup/Bacampicillin.pdf

Bacampicillin is a penicillin antibiotic. It is a prodrug of ampicillin with improved oral bioavailability. It exerts bactericidal activity via inhibition of bacterial cell wall synthesis by binding one or more of the penicillin binding proteins (PBPs). Spectrobid is used to treat bacterial infections such as tonsillitis, pneumonia (lung infection), bronchitis (inflammation of airway), urinary tract infections, gonorrhea, and infections of the skin. Adverse effects are: anemia, thrombocytopenia, neutropenia, agranulocytosis, seizures, nephrotoxicity, Jarisch-Herxheimer Reaction (fever, chills, sweating, tachycardia, hyperventilation, flushing, and myalgia). Drug interactions: Contraceptives - decreased contraceptive effectiveness; Live Typhoid Vaccine - decreased immunological response to the typhoid vaccine; Probenecid - increased bacampicillin levels.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
SPECTROBID

Approved Use

Bacampicillin is used to treat many different types of infections, such as tonsillitis, pneumonia, bronchitis, urinary tract infections, gonorrhea, and infections of the skin.

Launch Date

3.46291208E11
Curative
SPECTROBID

Approved Use

Bacampicillin is used to treat many different types of infections, such as tonsillitis, pneumonia, bronchitis, urinary tract infections, gonorrhea, and infections of the skin.

Launch Date

3.46291208E11
Curative
SPECTROBID

Approved Use

Bacampicillin is used to treat many different types of infections, such as tonsillitis, pneumonia, bronchitis, urinary tract infections, gonorrhea, and infections of the skin.

Launch Date

3.46291208E11
Curative
SPECTROBID

Approved Use

Bacampicillin is used to treat many different types of infections, such as tonsillitis, pneumonia, bronchitis, urinary tract infections, gonorrhea, and infections of the skin

Launch Date

3.46291208E11
Curative
SPECTROBID

Approved Use

Bacampicillin is used to treat many different types of infections, such as tonsillitis, pneumonia, bronchitis, urinary tract infections, gonorrhea, and infections of the skin.

Launch Date

3.46291208E11
Curative
SPECTROBID

Approved Use

Bacampicillin is used to treat many different types of infections, such as tonsillitis, pneumonia, bronchitis, urinary tract infections, gonorrhea, and infections of the skin.

Launch Date

3.46291208E11
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
13.5 μg/mL
808 mg single, oral
dose: 808 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BACAMPICILLIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
3.09 μg × min/mL
808 mg single, oral
dose: 808 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
BACAMPICILLIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
3200 mg single, oral
Highest studied dose
Dose: 3200 mg
Route: oral
Route: single
Dose: 3200 mg
Sources:
healthy, 22-41 years
n = 12
Health Status: healthy
Age Group: 22-41 years
Sex: M+F
Population Size: 12
Sources:
1600 mg 2 times / day multiple, oral
Highest studied dose
Dose: 1600 mg, 2 times / day
Route: oral
Route: multiple
Dose: 1600 mg, 2 times / day
Sources:
unhealthy
n = 16
Health Status: unhealthy
Condition: chronic bronchitis
Population Size: 16
Sources:
PubMed

PubMed

TitleDatePubMed
Clinical trial of bacampicillin in acute bacterial infections.
1983
beta-Lactam drug allergens: fine structural recognition patterns of cephalosporin-reactive IgE antibodies.
1996 Jul-Aug
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients.
2001 Nov
Patents

Sample Use Guides

Upper respiratory tract infections, Urinary tract infections, skin infections: 400 mg q12h; treat for a minimum of 48-72 hours after the patient becomes asymptomatic. Severe infections: 800 mg q12h; treat for a minimum of 48-72 hours after the patient becomes asymptomatic.
Route of Administration: Oral
Bacampicillin-treated lymphocyte cultures (200 ug/ml) from the two retested patients with allergic contact dermatitis showed an IFN-gamma production that peaked at 96 h or later. The four retested patients with rhinitis showed no or low IFN-gamma production which peaked at 48 h or 72 h. Two of them responded with IL-4 production.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:49:50 UTC 2023
Edited
by admin
on Fri Dec 15 15:49:50 UTC 2023
Record UNII
PM034U953T
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BACAMPICILLIN HYDROCHLORIDE
EP   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN  
Official Name English
BACAMPICILLIN HYDROCHLORIDE [EP MONOGRAPH]
Common Name English
BACAMPICILLIN HCL
Common Name English
BACAMPICILLIN HYDROCHLORIDE [USAN]
Common Name English
BACAMPICILLIN HYDROCHLORIDE [MART.]
Common Name English
BACAMPICILLIN HYDROCHLORIDE [JAN]
Common Name English
BACAMPICILLIN HYDROCHLORIDE [USP IMPURITY]
Common Name English
BACAMPICILLIN HYDROCHLORIDE [VANDF]
Common Name English
BACAMPICILLIN HYDROCHLORIDE [MI]
Common Name English
4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-((AMINOPHENYLACETYL)AMINO)-3,3-DIMETHYL-7-OXO-, 1-((ETHOXYCARBONYL)OXY)ETHYL ESTER, MONOHYDROCHLORIDE, (2S-(2.ALPHA.,5.ALPHA.,6.BETA.(S*)))-
Common Name English
Bacampicillin hydrochloride [WHO-DD]
Common Name English
SPECTROBID
Brand Name English
BECAMPICILLIN HYDROCHLORIDE
Common Name English
BACAMPICILLIN HYDROCHLORIDE [ORANGE BOOK]
Common Name English
NSC-758228
Code English
(2S,5R,6R)-6-[(R)-(2-Amino-2-phenylacetamido)]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ester with ethyl 1-hydroxyethyl carbonate, monohydrochloride
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1500
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
Code System Code Type Description
PUBCHEM
441398
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
EVMPD
SUB00649MIG
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
MESH
C011674
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
FDA UNII
PM034U953T
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
EPA CompTox
DTXSID0045466
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
DRUG BANK
DBSALT000831
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
CAS
37661-08-8
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
ChEMBL
CHEMBL1583
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
CHEBI
2969
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
ECHA (EC/EINECS)
253-580-4
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
SMS_ID
100000092774
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
RXCUI
327584
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY RxNorm
EVMPD
SUB32681
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
NSC
758228
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
NCI_THESAURUS
C65246
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY
MERCK INDEX
m2194
Created by admin on Fri Dec 15 15:49:50 UTC 2023 , Edited by admin on Fri Dec 15 15:49:50 UTC 2023
PRIMARY Merck Index
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY